IGEN BIOLAB GROUP microbiome modulation discovery technologies generate and evaluate small molecules, peptide biologic and bacteria strains that modulate microbe and microbe-human interactions that can contribute to health and disease. These technologies allow IGEN BIOLAB GROUP to identify key microbial community members, activities and metabolites, and assay for modulatory potential against host targets of interest.

These capabilities combine IGEN BIOLAB GROUP depth of experience in microbiome research with proprietary and licensed technology for metagenomic assays, comprehensive bioinformatics pipelines, and novel in vitro and in vivo assays.